Skip to content
2000
Volume 27, Issue 26
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The history of colchicine dates to ancient Egyptians when it was used for alleviation of swelling and pain. Although its popularity varied throughout the years, colchicine has been a mainstay for the treatment of several diseases, mainly rheumatic and cardiac ones. The mechanism of action of the drug involves several intracellular and extracellular targets, although interaction with tubulin is the most described. Based on several clinical trials and meta-analyses, colchicine is safely recommended as a monotherapy or as an add-on for the treatment and prevention of recurrent pericarditis, post-pericardiotomy syndrome, gout, pseudogout, familial Mediterranean fever (FMF), and Behçet’s disease (BD). Notably, drug safety has been noted during pregnancy and lactation. Besides its major indications, colchicine has shown efficacy and safety in the treatment of various conditions. Because the indications for using colchicine in the prevention of certain conditions such as acute coronary syndrome, stroke, and hepatic cirrhosis and treatment of others such as pneumonia and psoriasis are still debatable, further research works are needed.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666201023144320
2021-07-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666201023144320
Loading

  • Article Type:
    Review Article
Keyword(s): colchicine; Drug history; efficacy; guidelines; pharmacology; safety
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test